低容量中心成功从开胸手术转向电视辅助胸腔镜肺叶切除术治疗非小细胞肺癌
冰岛一家低容量中心于2019年初在一位资深外科医生赴海外接受VATS培训后,一夜之间从开胸手术转向VATS肺叶切除术,并立即成为非小细胞肺癌手术治疗的主流。该回顾性研究分析了2019—2022年冰岛所有因非小细胞肺癌行肺切除术的病例,重点为cTNM I或II期的VATS肺叶切除术,结果显示短期结局与大型高容量中心相当。
要点
- 204例肺切除术中169例为肺叶切除术(82.9%),其中147例(87.0%)为VATS肺叶切除术。
- VATS肺叶切除术后中位住院4天,平均手术时间从研究第一年的155分钟降至最后一年的124分钟(P < 0.001)。
- 主要并发症发生率2.7%,次要并发症15.6%,术后30天全部存活,一年生存率95.6%。
核心结论
- 在服务39万人口的小型地理隔离中心,VATS肺叶切除术的实施是成功的,尽管技术具有挑战性,但大多数非小细胞肺癌病例快速实施了VATS肺叶切除术,短期结局与大型高容量中心相当。
研究设计与样本
- 回顾性研究,纳入2019—2022年冰岛所有因非小细胞肺癌行肺切除术的病例,重点为cTNM I或II期的VATS肺叶切除术,数据来自医院病历,包括围手术期并发症、死亡率、住院时间和手术时间。
主要发现
- 204例肺切除术中,169例为肺叶切除术(82.9%),其中147/169(87.0%)为VATS肺叶切除术。
- 前外侧开胸用于34例(16.7%),包括22例肺叶切除术(64.7%),以及5例(3.4%)从VATS肺叶切除术中转。
- VATS肺叶切除术后中位住院时间为4天,平均手术时间从研究第一年的155分钟降至最后一年的124分钟(P < 0.001)。
- 主要并发症发生率为2.7%,次要并发症发生率为15.6%。
- 一年生存率为95.6%,所有患者术后30天均存活。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Although video-assisted thoracoscopic surgery (VATS) lobectomy has become the gold standard for pulmonary resections of non-small-cell lung cancer (NSCLC), lobectomy is still performed via thoracotomy in many European and North American centres. VATS lobectomy was implemented overnight from thoracotomy in our low-volume centre in early 2019, after 1 senior surgeon undertook observership VATS-training overseas, and immediately became the mainstay of surgical treatment for NSCLC in Iceland. We aimed to investigate our short-term outcomes of VATS lobectomy. METHODS: This was a retrospective study on all pulmonary resections for NSCLC in Iceland 2019-2022, especially focusing on VATS lobectomies, all at cTNM stage I or II. Data were retrieved from hospital charts, including information on perioperative complications, mortality, length of stay and operation time. RESULTS: Out of 204 pulmonary resections, mostly performed by a single senior cardiothoracic surgeon, 169 were lobectomies (82.9%) with 147 out of 169 (87.0%) being VATS lobectomies. Anterolateral thoracotomy was used in 34 cases (16.7%), including 22 lobectomies (64.7%), and 5 (3.4%) conversions from VATS lobectomy. The median postoperative stay for VATS lobectomy was 4 days and the average operating time decreased from 155 to 124 min between the first and last year of the study (P < 0.001). The rate of major and minor complications was 2.7% and 15.6% respectively. One year survival was 95.6% and all patients survived 30 days postoperatively. CONCLUSIONS: The implementation of VATS lobectomy has been successful in our small geographically isolated centre, serving a population of 390 000. Although technically challenging, VATS lobectomy was implemented fast for most NSCLC cases, with short-term outcomes that are comparable to larger high-volume centres.
引用
- Asbjornsson V, Johannsdottir G, Myer D, et al. A successful shift from thoracotomy to video-assisted thoracoscopic lobectomy for non-small cell lung cancer in a low-volume center. Interdiscip Cardiovasc Thorac Surg. 2024. PMID: 38290794. doi:10.1093/icvts/ivae018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。